Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsOpinionIT, pharma can gain from Trump presidency despite higher trade barriers

    IT, pharma can gain from Trump presidency despite higher trade barriers

    Vendor diversification and higher duties on China can benefit CDMO and chemical companies. Though renewable energy adoption can see lesser policy support

    R. Sree Ram
    November 07, 2024 / 08:16 IST
    US President-elect Donald Trump
    • PRO Panorama

      Moneycontrol Pro Panorama | After a turbulent 2025 for stock markets, will 2026 bring cheer?

      Nov 11, 2025 / 03:24 PM IST

      In November 11 edition of Moneycontrol Pro Panorama: Amid EC’s second phase of SIR legal challenges intensify, the US is wooing ...

      Read Now
    Unlock This Article

    Are you a PRO subscriber? Sign In

    What Do You Get

    • Ad free Experience

      Seamless navigation, faster responses.

    • Expert Perspective

      Explore 230+ exclusive editorials every month

    • +

      Uncover Insights from World-Renowned Experts and Journalists

    • Actionable Insights

      40+ weekly investment ideas + 3 to 4 daily technical calls

    • Virtual Events

      Exclusive Live Webinars for Expert Trading & Investment Strategies!

    • Newsletters

      Stay ahead with daily and weekly insights

    View Offers

    Unlock exclusive discounts